Induced B-Cell Receptor Diversity Predicts PD-1 Blockade Immunotherapy Response.
Yonglu Che, Jinwoo Lee, Farah Abou-Taleb, Kerri E. Rieger, Ansuman T. Satpathy, Anne Lynn S. Chang, Howard Y. Chang
This study identifies induced B-cell receptor diversity as a predictor of PD-1 blockade immunotherapy response across multiple cancer types.
Proceedings of the National Academy of Sciences · May 2, 2025Peer-reviewedCancer Biology